| |
Latest 10 SEC filings (by transaction date) for RCUS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 29/24 | Mar 27/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -11,551 | $17.55 |
Mar 20/24 | Mar 18/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -1,296 | $18.62 |
Mar 20/24 | Mar 18/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -12,153 | $17.84 |
Feb 28/24 | Feb 27/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -34,070 | $20.11 |
Feb 28/24 | Feb 27/24 | Jaen Juan C. | Indirect Ownership | Common Stock | S - Open market or private sale | -23,132 | $20.10 |
Feb 28/24 | Feb 26/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -24,555 | $20.07 |
Feb 28/24 | Feb 26/24 | Jaen Juan C. | Indirect Ownership | Common Stock | S - Open market or private sale | -3,900 | $20.06 |
Feb 7/24 | Feb 7/24 | Mercier Johanna | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 31/24 | Jan 29/24 | Gilead Sciences, Inc. | Direct Ownership | Common Stock | P - Open market or private purchase | 15,238,095 | $21.00 |
Feb 23/24 | Jan 23/24 | Goeltz II Robert C. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 22,000 | |
Sign up or login above to see all SEC filings within the past 6 months. |
Latest 10 SEC filings (by filing date) for RCUS within the last 6 months | [?] |
Amended Filing Footnote and/or Remark |
Filing Date | Transaction Date | Insider Name | Ownership Type | Securities | Nature of transaction | Volume or Value | Price |
---|---|---|---|---|---|---|---|
Mar 29/24 | Mar 27/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -11,551 | $17.55 |
Mar 20/24 | Mar 18/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -1,296 | $18.62 |
Mar 20/24 | Mar 18/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -12,153 | $17.84 |
Feb 28/24 | Feb 27/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -34,070 | $20.11 |
Feb 28/24 | Feb 26/24 | Jarrett Jennifer | Direct Ownership | Common Stock | S - Open market or private sale | -24,555 | $20.07 |
Feb 28/24 | Feb 27/24 | Jaen Juan C. | Indirect Ownership | Common Stock | S - Open market or private sale | -23,132 | $20.10 |
Feb 28/24 | Feb 26/24 | Jaen Juan C. | Indirect Ownership | Common Stock | S - Open market or private sale | -3,900 | $20.06 |
Feb 23/24 | Jan 23/24 | Goeltz II Robert C. | Direct Ownership | Common Stock | A - Grant, award or other under Rule 16b-3(d) | 22,000 | |
Feb 7/24 | Feb 7/24 | Mercier Johanna | Direct Ownership | Common Stock | Form 3 : Initial Statement of Beneficial Ownership of Securities | ||
Jan 31/24 | Jan 29/24 | Gilead Sciences, Inc. | Direct Ownership | Common Stock | P - Open market or private purchase | 15,238,095 | $21.00 |
Sign up or login above to see all SEC filings within the past 6 months. |
Sign up or login above to see the past 6 months of filings sorted by insider. . |
Competitors with Recent Insider Filings |
Medpace Holdings (OQ:MEDP) |
United Therapeutics (OQ:UTHR) |
Disc Medicine (OQ:IRON) |